Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mona A, Fouladi"'
Autor:
Soumyabrata Roy, Pierre-Grégoire Coulon, Ruchi Srivastava, Hawa Vahed, Grace J. Kim, Sager S. Walia, Taikun Yamada, Mona A. Fouladi, Vincent T. Ly, Lbachir BenMohamed
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Recurrent viral diseases often occur after the viruses evade the hosts' immune system, by inducing exhaustion of antiviral T cells. In the present study, we found that functionally exhausted herpes simplex virus type 1 (HSV-1) -specific CD8+ T cells,
Externí odkaz:
https://doaj.org/article/9f47eaf262ab4dae873ed33e6fb57b56
Autor:
Ruchi Srivastava, Cynthia Lam, Albert Zlotnik, Vincent T. Ly, Sheilouise A. B. Sarain, Mona A. Fouladi, Grace J. Kim, Lbachir BenMohamed, Taikun Yamada, Undariya Boldbaatar, Elmostafa Bahraoui, Arif A. Khan, Marcela Hernandez-Ruiz
Publikováno v:
The Journal of Immunology. 200:2915-2926
Circulating conventional memory CD8+ T cells (i.e., the CD8+ effector memory T [TEM] cell and CD8+ central memory T [TCM] cell subsets) and the noncirculating CD8+ tissue-resident memory T (TRM) cell subset play a critical role in mucosal immunity. M
Autor:
Soumyabrata Roy, Cynthia Lam, Hawa Vahed, Sager S. Walia, Lbachir BenMohamed, Undariya Boldbaatar, Anthony Lou, Vivianna Nguyen, Grace J. Kim, Roger Geertsema, Taikun Yamada, Vincent T. Ly, Mona A. Fouladi, Arif A. Khan, Nigel W Fraser, Ruchi Srivastava
Publikováno v:
Journal of Virology. 92
Herpes simplex virus 1 (HSV-1) is a prevalent human pathogen that infects the cornea, causing potentially blinding herpetic disease. A clinical herpes vaccine is still lacking. In the present study, a novel prime/pull vaccine was tested in a human le
Autor:
Arif A, Khan, Ruchi, Srivastava, Hawa, Vahed, Soumyabrata, Roy, Sager S, Walia, Grace J, Kim, Mona A, Fouladi, Taikun, Yamada, Vincent T, Ly, Cynthia, Lam, Anthony, Lou, Vivianna, Nguyen, Undariya, Boldbaatar, Roger, Geertsema, Nigel W, Fraser, Lbachir, BenMohamed
Publikováno v:
Journal of virology. 92(16)
There is an urgent need for a vaccine against widespread herpes simplex virus infections. The present study demonstrates that immunization of HLA transgenic rabbits with a peptide/CXCL10 prime/pull vaccine triggered mobilization of HSV-specific CD8+